CVS Health (CVS) closed the most recent trading day at $101.56, moving -0.81% from the previous trading session. This change was narrower than the S&P 500's daily loss of 1.89%. At the same time, the Dow lost 1.3%, and the tech-heavy Nasdaq lost 0.17%.

Coming into today, shares of the drugstore chain and pharmacy benefits manager had gained 1.07% in the past month. In that same time, the Retail-Wholesale sector lost 6.12%, while the S&P 500 lost 1.79%.

Investors will be hoping for strength from CVS Health as it approaches its next earnings release, which is expected to be February 9, 2022. The company is expected to report EPS of $1.78, up 36.92% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $75.27 billion, up 8.23% from the year-ago period.

Any recent changes to analyst estimates for CVS Health should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.2% higher within the past month. CVS Health currently has a Zacks Rank of #3 (Hold).

Looking at its valuation, CVS Health is holding a Forward P/E ratio of 12.42. This valuation marks a premium compared to its industry's average Forward P/E of 10.55.

It is also worth noting that CVS currently has a PEG ratio of 1.6. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Retail - Pharmacies and Drug Stores stocks are, on average, holding a PEG ratio of 1.98 based on yesterday's closing prices.

The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 197, which puts it in the bottom 23% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow CVS in the coming trading sessions, be sure to utilize Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CVS Health Corporation (CVS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.